SYNTEX EXEC VP PAUL FREIMAN IS FIRM's NEW PRESIDENT; THOMAS GUTSHALL TO EXEC VP

Syntex' new president is 24-year veteran Paul Freiman, 52, who assumes that title effective Jan. 1, 1987 from current Chairman and Chief Exec Albert Bowers, PhD. Bowers, 56, has held the additional title of president since the retirement of Richard Rogers a year ago. Currently exec VP responsible for Syntex' worldwide pharmaceutical and agribusiness activities, Freiman will add responsibilities for the company's diagnostic business. He will also hold the title of chief operating officer and will continue to hold a seat on the board of directors. Freiman joined Syntex in 1962 as a professional service representative. He was elected head of marketing at Syntex Labs in 1972 and president of the subsidiary in 1978. Moving to exec VP is Thomas Gutshall, 48, currently senior VP and president of Syntex Diagnostics with responsibility for the company's medical diagnostics, chemical operations and engineering services group. In addition to his current duties, Gutshall will also join Syntex' Pharmaceutical Executive Committee, which includes Freiman, Syntex Labs President Thomas Hoffmeister, and Syntex Pharmaceutical International VP President John Munson. Gutshall joined Syntex in 1981 as group VP of Syntex U.S.A. in charge of the company's engineering, production technical services and bulk pharmaceutical chemical manufacturing operations worldwide. He was named president of Syntex Diagnostics in 1983.